Items where Author is "Xander, Nicolas S.H."

Salcher-Konrad, Maximilian; Xander, Nicolas S.H.; Hendrickx, Anne; Walter, Melanie (2026): Access-based pricing: empirical evaluation of a new pricing model for newly authorised medicines. EuHEA Conference 2026, 15. Juli 2026, Rotterdam

Salcher-Konrad, Maximilian; Hendrickx, Anne; Xander, Nicolas S.H. (2026): Incentivising innovation and ensuring access: An access-based pricing model for newly authorised medicines. 9th ATHEA Conference “Equality in Times of Economic Slowdown", 27. Februar 2026, Wien

Uyl-de Groot, Carin A.; Xander, Nicolas S.H.; Belleman, Tom; Burger, Emily A.; Doeswijk, Robin; Durand-Zaleski, Isabelle; Geisler, Benjamin P.; Groene, Oliver; Hendrickx, Anne; Henkel, Pia S.; Heine, Renaud; Huić, Mirjana; Melli, Mauro; Morgan, Kate; Racovita, Monica; Quinonez, Gautier; Rutten-van Mölken, Maureen P.M.H.; Tesař, Tomáš; Thielen, Frederick W.; Schneider, Peter; Salcher-Konrad, Maximilian; Wu, Yansi; Aas, Eline (2026): Bridging Affordability and Sustainability of Health Innovations via Novel Pricing, Cost-effectiveness, and Reimbursement Models to Improve Patient Access: The ASCERTAIN Project. Health Policy and Technology. p. 101155

Uyl-de Groot, Carin A.; Xander, Nicolas S.H.; Salcher-Konrad, Maximilian (2025): Auf dem Weg zu einer gerechten und nachhaltigen Preisgestaltung im Gesundheitswesen: Fokus auf das AIM-Fair-Price-Modell und das ASCERTAIN-Projekt. In: Arzneimittel-Kompass 2025. Springer, Berlin, pp. 153-164

Xander, Nicolas S.H.; Salcher-Konrad, Maximilian; Hendrickx, Anne; Thielen, Frederick W.; Uyl-de Groot, Carin A. (2025): HPR129 Introducing an Access-Based Pricing Model to Determine Prices and Inform Price Negotiations for Newly Authorized Medicinal Products. Value in Health, 28 (12). p. 346